Moderna CEO Stéphane Bancel received an annual compensation package worth $19.87 million last year, the largest he’s ever ...

Shares of Moderna MRNA rose nearly 16% yesterday after a couple of SEC filings showed that two board members bought shares on the open market. It also secured a legal victory in a patent dispute ...

Stéphane Bancel, CEO of Moderna at the Fast Company Innovation ... obsessed with ChatGPT since it was released at the end of 2022, and that his goal is for Moderna’s employees to use it no ...

Tyson Foods CEO Donnie King has seen his annual executive rewards leap from $13 million in 2023 to $22.7 million in 2024. To ...

The CEO of Moderna Inc. (NASDAQ: MRNA) just purchased $5 million of stock in the open market. This is very significant since most of the insider trades have been sales for the past year.

Also in August 2022, we initiated patent infringement ... $40bn in revenues in the past few years. A few days ago, Moderna's CEO Stephane Bancel reportedly made two large purchases of Moderna ...

Shares of the American pharmaceutical company Moderna (MRNA) climbed over 8% in pre-market trading following strategic insider stock purchases by the CEO and director. This comes as a significant ...

Stéphane Bancel discusses the company’s new Covid-19 boosters, its approach to developing vaccines for emerging variants alongside seasonal flu shots, and the use of mRNA technology to treat cancer ...

Richardson: This week, in place of Journal Club, we have a very special episode featuring Stéphane Bancel, CEO of Moderna, in conversation with you, Hanne, and a16z General Partner Jorge Conde.

U.S. pharmaceutical firm Moderna Inc. is negotiating with the Japanese government regarding the company’s plans to build a factory in Japan to manufacture its vaccines, its CEO said on Sept.

In a couple of regulatory filings with the SEC, it was revealed that Moderna’s CEO Stephane Bancel and director ... revoked its permission in March 2022. This meant that Pfizer and BioNTech ...